DALGARNO, DAVID C.,HUANG, WEI-SHENG,SHAKESPEARE, WILLIAM C.,WANG, YIHAN,ZHU, XIAOTIAN
申请号：
CA2832504
公开号：
CA2832504C
申请日:
2012.05.04
申请国别(地区):
CA
年份:
2019
代理人:
摘要：
The invention features compounds, pharmaceutical compositions and methods for treating patients who have an EGFR-driven cancer of formula (I), wherein the variables are as defined herein.
